Download PDF
Semin intervent Radiol 2022; 39(01): 119-122
DOI: 10.1055/s-0042-1742345
Clinical Corner

Adenomyosis – An Overview

Stephanie Wong
1   Department of Radiology, University of Illinois College of Medicine, Chicago, Illinois
,
Charles E. Ray Jr.
1   Department of Radiology, University of Illinois College of Medicine, Chicago, Illinois
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Adenomyosis is a benign uterine disorder in which there is a pathological presence of endometrial glands and stroma in the myometrium. Symptoms can include abnormal uterine bleeding, dysmenorrhea, dyspareunia, or infertility; one-third of women, however, remain asymptomatic.[1] [2] Since many of these symptoms also occur in other gynecological diseases such as endometriosis and uterine fibroids, which often co-exist with adenomyosis, making a clinical diagnosis can be difficult. In the past, adenomyosis was only diagnosed on histopathology after a hysterectomy. With the combination of a patient's risk factor profile, clinical symptoms, and imaging diagnostic tools such as transvaginal ultrasound (TVUS) and magnetic resonance imaging (MRI), clinicians are able to identify adenomyosis in a non-invasive way.[1] [3] [4] [5] The diagnosis of adenomyosis has been increasing in young women of reproductive age and conservative treatment is essential in those who prefer to maintain fertility.[1] [5] Since adenomyosis greatly impacts quality of life, it is important for clinicians to properly diagnose and treat these women to optimize clinical outcome.



Publication History

Article published online:
18 February 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Vannuccini S, Petraglia F. Recent advances in understanding and managing adenomyosis. F1000Res. 2019 Mar 13;8:F1000 Faculty Rev-283. doi: 10.12688/f1000research.17242.1. PMID: 30918629; PMCID: PMC6419978.
    PubMedGoogle Scholar
  • 2 Yu O, Schulze-Rath R, Grafton J, Hansen K, Scholes D, Reed SD. Adenomyosis incidence, prevalence and treatment: United States population-based study 2006-2015. Am J Obstet Gynecol 2020; 223 (01) 94.e1-94.e10 DOI: 10.1016/j.ajog.2020.01.016.
    CrossrefPubMedGoogle Scholar
  • 3 Chapron C, Vannuccini S, Santulli P. et al. Diagnosing adenomyosis: an integrated clinical and imaging approach. Hum Reprod Update 2020; 26 (03) 392-411 DOI: 10.1093/humupd/dmz049.
    CrossrefPubMedGoogle Scholar
  • 4 Bae SH, Kim MD, Kim GM. et al. Uterine Artery Embolization for Adenomyosis: Percentage of Necrosis Predicts Midterm Clinical Recurrence. J Vasc Interv Radiol 2015; 26 (09) 1290-6.e2 DOI: 10.1016/j.jvir.2015.04.026.
    CrossrefPubMedGoogle Scholar
  • 5 Dessouky R, Gamil SA, Nada MG, Mousa R, Libda Y. Management of uterine adenomyosis: current trends and uterine artery embolization as a potential alternative to hysterectomy. Insights Imaging 2019; 10 (01) 48 DOI: 10.1186/s13244-019-0732-8.
    CrossrefPubMedGoogle Scholar
  • 6 Zhou J, He L, Liu P. et al. Outcomes in Adenomyosis Treated with Uterine Artery Embolization Are Associated with Lesion Vascularity: A Long-Term Follow-Up Study of 252 Cases. PLoS One 2016; 11 (11) e0165610 DOI: 10.1371/journal.pone.0165610.
    CrossrefPubMedGoogle Scholar
  • 7 Antero MF, Ayhan A, Segars J, Shih IM. Pathology and Pathogenesis of Adenomyosis. Semin Reprod Med 2020;38(2-03):108–118 Epub2020Oct20. DOI: 10.1055/s-0040-1718922
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Popovic M, Puchner S, Berzaczy D, Lammer J, Bucek RA. Uterine artery embolization for the treatment of adenomyosis: a review. J Vasc Interv Radiol 2011; 22 (07) 901-909 , quiz 909. DOI: 10.1016/j.jvir.2011.03.013.
    CrossrefPubMedGoogle Scholar
  • 9 Vannuccini S, Luisi S, Tosti C, Sorbi F, Petraglia F. Role of medical therapy in the management of uterine adenomyosis. Fertil Steril 2018; 109 (03) 398-405 DOI: 10.1016/j.fertnstert.2018.01.013.
    CrossrefPubMedGoogle Scholar
  • 10 Sheng J, Zhang WY, Zhang JP, Lu D. The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis. Contraception 2009; 79 (03) 189-193 DOI: 10.1016/j.contraception.2008.11.004.
    CrossrefPubMedGoogle Scholar
  • 11 Ozdegirmenci O, Kayikcioglu F, Akgul MA. et al. Comparison of levonorgestrel intrauterine system versus hysterectomy on efficacy and quality of life in patients with adenomyosis. Fertil Steril 2011; 95 (02) 497-502
    CrossrefPubMedGoogle Scholar
  • 12 Ludwig PE, Huff TJ, Shanahan MM, Stavas JM. Pregnancy success and outcomes after uterine fibroid embolization: updated review of published literature. Br J Radiol 2020; 93 (1105): 20190551 DOI: 10.1259/bjr.20190551.
    CrossrefPubMedGoogle Scholar
  • 13 de Bruijn AM, Ankum WM, Reekers JA. et al. Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 10-year outcomes from the randomized EMMY trial. Am J Obstet Gynecol 2016; 215 (06) 745.e1-745.e12 DOI: 10.1016/j.ajog.2016.06.051.
    CrossrefPubMedGoogle Scholar
  • 14 Aoki M, Tokue H, Miyazaki M, Shibuya K, Hirasawa S, Oshima K. Primary postpartum hemorrhage: outcome of uterine artery embolization. Br J Radiol 2018; 91 (1087): 20180132 DOI: 10.1259/bjr.20180132.
    CrossrefPubMedGoogle Scholar
  • 15 Kohi MP, Spies JB. Updates on uterine artery embolization. Semin Intervent Radiol 2018; 35 (01) 48-55
    Article in Thieme ConnectPubMedGoogle Scholar
  • 16 Resnick NJ, Kim E, Patel RS, Lookstein RA, Nowakowski FS, Fischman AM. Uterine artery embolization using a transradial approach: initial experience and technique. J Vasc Interv Radiol 2014; 25 (03) 443-447
    CrossrefPubMedGoogle Scholar
  • 17 Spencer EB, Stratil P, Mizones H. Clinical and periprocedural pain management for uterine artery embolization. Semin Intervent Radiol 2013; 30 (04) 354-363
    Article in Thieme ConnectPubMedGoogle Scholar
  • 18 Binkert CA, Hirzel FC, Gutzeit A, Zollikofer CL, Hess T. Superior hypogastric nerve block to reduce pain after uterine artery embolization: advanced technique and comparison to epidural anesthesia. Cardiovasc Intervent Radiol 2015; 38 (05) 1157-1161
    CrossrefPubMedGoogle Scholar
  • 19 Noel-Lamy M, Tan KT, Simons ME, Sniderman KW, Mironov O, Rajan DK. Intraarterial lidocaine for pain control in uterine artery embolization: a prospective, randomized study. J Vasc Interv Radiol 2017; 28 (01) 16-22
    CrossrefPubMedGoogle Scholar
  • 20 de Bruijn AM, Smink M, Lohle PNM. et al. Uterine Artery Embolization for the Treatment of Adenomyosis: A Systematic Review and Meta-Analysis. J Vasc Interv Radiol 2017; 28 (12) 1629-1642.e1 DOI: 10.1016/j.jvir.2017.07.034.
    CrossrefPubMedGoogle Scholar
  • 21 Zhang L, Rao F, Setzen R. High intensity focused ultrasound for the treatment of adenomyosis: selection criteria, efficacy, safety and fertility. Acta Obstet Gynecol Scand 2017; 96 (06) 707-714 DOI: 10.1111/aogs.13159.
    CrossrefPubMedGoogle Scholar
  • 22 Marques ALS, Andres MP, Kho RM, Abrão MS. Is High-intensity Focused Ultrasound Effective for the Treatment of Adenomyosis? A Systematic Review and Meta-analysis. J Minim Invasive Gynecol 2020; 27 (02) 332-343 DOI: 10.1016/j.jmig.2019.07.029.
    CrossrefPubMedGoogle Scholar
  • 23 McCausland V, McCausland A. The response of adenomyosis to endometrial ablation/resection. Hum Reprod Update 1998; 4 (04) 350-359 DOI: 10.1093/humupd/4.4.350.
    CrossrefPubMedGoogle Scholar